Streetbeat News

ELV

Elevance Health Inc.

https://www.elevancehealth.com

Industry

Medical - Healthcare Plans

Elevance Health Inc. operates as a health benefits company. It supports consumers, families, and communities across the entire care journey connecting to the care, support, and resources to lead healthier lives. It serves approximately 118 million people through a portfolio of medical, digital, pharmacy, behavioral, clinical, and care solutions. The company was formerly known as Anthem, Inc. and changed its name to Elevance Health Inc. in June 2022. Elevance Health Inc. was founded in 1944 and is headquartered in Indianapolis, Indiana.

Open

405.00

Mkt cap

93B

Volume

2.6M

High

408.58

P/E Ratio

14.58

52-wk high

567.26

Low

398.69

Div yield

0.02

52-wk low

397.98

Barclays analyst Andrew Mok maintains an Overweight rating on Elevance Health (NYSE:ELV) but lowers the price target from $621 to $611.

Portfolio Pulse from Benzinga Newsdesk

July 18, 2024 | 3:26 pm

Elevance Health shares are trading lower after B of A Securities downgraded the stock from Buy to Neutral and cut its price target from $646 to $530.

Portfolio Pulse from Benzinga Newsdesk

July 18, 2024 | 2:33 pm

RBC Capital analyst Ben Hendrix maintains an Outperform rating on Elevance Health (NYSE:ELV) and raises the price target from $575 to $585.

Portfolio Pulse from Benzinga Newsdesk

July 18, 2024 | 2:12 pm

B of A Securities has downgraded Elevance Health (NYSE:ELV) from Buy to Neutral and lowered the price target from $646 to $530.

Portfolio Pulse from Benzinga Newsdesk

July 18, 2024 | 11:09 am

Healthcare investors are anticipating that a potential Trump administration could ease regulations on Medicare Advantage, which may benefit health insurers like UnitedHealth, Cigna, and Humana. This expectation has led to mixed results in the health insurance sector, with some stocks rising and others falling. ETFs holding health insurer stocks have generally trended upward.

Portfolio Pulse from Michael Juliano

July 17, 2024 | 8:09 pm

The Nasdaq 100 experienced its worst day in 11 months, driven by a broad selloff in semiconductor stocks following news of the Biden administration's accelerated export restrictions to China. Major chipmakers like ASML Holding and Nvidia saw significant declines, impacting related ETFs and indices. The S&P 500 and Russell 2000 also fell, while the Dow Jones rose. Other notable stock movements included significant drops in AMD, TSM, ARM, and SCHW, while JNJ rallied on strong earnings.

Portfolio Pulse from Piero Cingari

July 17, 2024 | 6:27 pm

Elevance Health shares are trading lower after reporting Q2 financial results and issuing FY24 adjusted diluted net income per share guidance below estimates.

Portfolio Pulse from Benzinga Newsdesk

July 17, 2024 | 2:22 pm

Elevance Health Inc. (NYSE: ELV) reported Q2 revenues of $43.2 billion, slightly above expectations, with a 24% profit increase. Despite a 5% drop in medical membership, the company maintained its annual guidance. ELV shares are down 3.82% in premarket trading.

Portfolio Pulse from Vandana Singh

July 17, 2024 | 1:22 pm

Elevance Health has announced its financial expectations for 2024, projecting a GAAP net income per diluted share of at least $34.05 and an adjusted diluted net income per share of at least $37.20. This is slightly below the consensus estimate of $37.28.

Portfolio Pulse from Benzinga Newsdesk

July 17, 2024 | 10:09 am

Elevance Health reported a Q2 total medical membership of 45.78 million, down 5% year-over-year. However, the benefit expense ratio improved by 10 basis points to 86.3%.

Portfolio Pulse from Benzinga Newsdesk

July 17, 2024 | 10:04 am

All corporate logos and prices are for illustrative purposes only and are not a recommendation, an offer to sell, or a solicitation of an offer to buy any security.